Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 03, 2022

SELL
$292.08 - $329.01 $813,734 - $916,621
-2,786 Closed
0 $0
Q3 2021

Oct 15, 2021

SELL
$272.21 - $332.43 $47,636 - $58,175
-175 Reduced 5.91%
2,786 $848,000
Q2 2021

Jul 20, 2021

SELL
$225.08 - $271.69 $61,897 - $74,714
-275 Reduced 8.5%
2,961 $795,000
Q4 2020

Jan 25, 2021

BUY
$212.5 - $245.46 $10,625 - $12,273
50 Added 1.57%
3,236 $719,000
Q3 2020

Oct 09, 2020

BUY
$177.16 - $215.33 $10,629 - $12,919
60 Added 1.92%
3,186 $686,000
Q1 2020

Apr 15, 2020

BUY
$121.39 - $169.05 $24,156 - $33,640
199 Added 6.8%
3,126 $433,000
Q4 2019

Jan 14, 2020

SELL
$133.47 - $153.48 $2,802 - $3,223
-21 Reduced 0.71%
2,927 $449,000
Q3 2019

Oct 25, 2019

BUY
$135.4 - $146.47 $5,686 - $6,151
42 Added 1.45%
2,948 $426,000
Q1 2019

Apr 29, 2019

SELL
$97.62 - $132.29 $6,833 - $9,260
-70 Reduced 2.35%
2,906 $384,000
Q4 2018

Jan 29, 2019

BUY
$94.85 - $109.54 $6,639 - $7,667
70 Added 2.41%
2,976 $307,000
Q2 2018

Jul 30, 2018

SELL
$96.1 - $103.24 $7,207 - $7,743
-75 Reduced 2.52%
2,906 $287,000
Q3 2017

Oct 19, 2017

BUY
$79.29 - $88.45 $236,363 - $263,669
2,981
2,981 $256,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $174B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Taylor, Cottrill, Erickson & Associates, Inc. Portfolio

Follow Taylor, Cottrill, Erickson & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Taylor, Cottrill, Erickson & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Taylor, Cottrill, Erickson & Associates, Inc. with notifications on news.